Pharmaceutical Business review

Moraga discovers flexible stem cell in adult tissue

The company’s scientists found that these adult stem cells were able to differentiate into most tissues and organs of the body – including spermatogonia. The company further said that its scientists are now able to clone these unique adult stem cells into various cell lines from a single cell.

Since new research points to the possibility that cancers arise as diseases of adult stem cells, the company believes these adult-derived stem cells may be an invaluable research tool for discovering new molecular pathways and drugs for treating and possibly curing many forms of cancer in the future.

“This recent discovery is a major breakthrough for the company. It makes possible new therapeutic approaches using adult stem cells in the field of regenerative medicine,” Moraga’s chief executive, Dr John Wong.